{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.61","meta":{"versionId":"10","lastUpdated":"2021-05-21T01:00:57.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.61","version":"20210521","name":"Cetuximab Injectable","status":"active","date":"2021-05-21T01:00:57-04:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"1657658","display":"50 ML cetuximab 2 MG/ML Injection"},{"code":"1657663","display":"100 ML cetuximab 2 MG/ML Injection"}]}]},"expansion":{"identifier":"urn:uuid:b8f71f97-e8af-4d1e-aae6-f4803e42aa5c","timestamp":"2022-06-10T05:39:02-04:00","total":2,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1657658","display":"50 ML cetuximab 2 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1657663","display":"100 ML cetuximab 2 MG/ML Injection"}]}}